Latest Blogs, Articles, and More View More >>
View More >>
The U.S. Food & Drug Administration has approved Odomzo (sonidegib) for the treatment of patients with locally advanced basal cell carcinoma who have experienced a recurrence of this condition after surgery or radiation, or who weren’t eligible for those therapies.
I decided to go ahead with my scheduled breast reduction. I’d wait for the genetic testing results, from two weeks to two months. I decided that, for me, breast reduction would still be my choice, even if I had genes that imposed a 50 percent to 80 percent increase in the likelihood of breast cancer. Those of you who read my last post have been waiting with me. I wanted to pose a real-time, real-life conundrum.
Male breast cancer survivor Khevin Barnes tells of an unexpected visitor–and an unforgettable lesson.
An online tool is designed to help men with prostate or other types of cancer deal with sexual dysfunction and other common side effects of treatment.
Oncology experts supported a patient-driven online petition asking Congress to give the government, patients and other stakeholders more power when it comes to negotiating prices for cancer drugs.
Practical tips on how to help a sick friend.
Colorectal cancer is the third leading cause of cancer-related deaths in the United States when men and women are considered separately, and the second leading cause when both sexes are combined.